Elsevier

Metabolism

Volume 64, Issue 1, January 2015, Pages 24-34
Metabolism

Leptin in the 21st Century
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism

https://doi.org/10.1016/j.metabol.2014.08.004Get rights and content

Abstract

Leptin is secreted by adipose tissue and regulates energy homeostasis, neuroendocrine function, metabolism, immune function and other systems through its effects on the central nervous system and peripheral tissues. Leptin administration has been shown to restore metabolic and neuroendocrine abnormalities in individuals with leptin-deficient states, including hypothalamic amenorrhea and lipoatrophy. In contrast, obese individuals are resistant to leptin. Recombinant leptin is beneficial in patients with congenital leptin deficiency or generalized lipodystrophy. However, further research on molecular mediators of leptin resistance is needed for the development of targeted leptin sensitizing therapies for obesity and related metabolic diseases.

Introduction

The discovery of leptin changed the knowledge of energy homeostasis and our view of adipose tissue from a simple energy depot to an active endocrine organ [1]. Leptin is mainly produced in adipose tissue and circulating leptin levels correlate well with the amount of body fat, reflecting energy status. Leptin plays an important role in regulating energy homeostasis, neuroendocrine and immune functions, and glucose, lipid and bone metabolism [2], [3]. While leptin administration reverses neuroendocrine and metabolic abnormalities in individuals with congenital leptin deficiency, common forms of obesity are typically associated with elevated leptin and resistance to leptin's effects on energy homeostasis [4]. Here, we review the biology of leptin, the current understanding of its physiologic and pathologic roles, and potential clinical applications.

Section snippets

Biology of leptin

Leptin is a 167-amino-acid peptide that is mainly expressed in white adipose tissue (WAT), but is also found in a variety of tissues including placenta, mammary gland, ovary, skeletal muscle, stomach, pituitary gland, and lymphoid tissue [5]. Circulating leptin levels are directly in proportion to the amount of body fat, thereby reflecting the status of long-term energy stores. In addition, leptin levels fluctuate according to changes in calorie intake with a marked decrease during starvation

Leptin and energy homeostasis

Leptin acts on LepRb-expressing neurons in the brain. In the arcuate nucleus (ARC), leptin interacts with a complex neural circuit to control food intake, activating anorexigenic neurons that synthesize pro-opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART), and inhibiting orexigenic neurons that synthesize agouti-related peptide (AgRP) and neuropeptide Y (NPY). During fasting, circulating leptin levels decline rapidly. The fall in leptin stimulates the expression

Leptin and neuroendocrine function

Leptin levels in adipose tissue and plasma fall rapidly during fasting. Circulating leptin levels decrease in overweight men after negative energy balance is achieved with exercise and calorie restriction, indicating that leptin levels reflect energy status [59]. Low leptin levels during fasting trigger metabolic and hormonal responses in mice and humans [11], [60], consisting of hyperphagia, hypogonadotropic hypogonadism, and suppression of thyroid and growth hormone (GH) levels, which are

Leptin and metabolism

Total leptin deficiency in ob/ob mice and individuals with congenital leptin deficiency results in insulin resistance, diabetes, steatosis and other features of metabolic syndrome. In ob/ob mice, leptin treatment rapidly decreases glucose, insulin and lipids before weight loss is achieved [53], [90] (Fig. 2). In morbidly obese individuals with congenital leptin deficiency, leptin replacement dramatically decreases insulin resistance, steatosis, dyslipidemia and glucose levels [54], [65].

Leptin and exercise

Successful long-term weight loss requires a reduction in food intake and an increase in physical activity. A negative energy balance achieved in 4 days by combining calorie restriction and exercise in obese subjects resulted in a rapid decline in leptin, indicating that changes in leptin levels reflect energy balance [59]. Human skeletal muscle expresses low levels of LepRb. As with plasma leptin levels, there is a sexual dimorphism in LepRb expression in human skeletal muscle, which could be

Leptin and immune function

Various studies have shown that leptin has important roles in modulating innate and adaptive immunity [144]. Leptin stimulates neutrophil chemotaxis and promotes macrophage phagocytosis, as well as production of pro-inflammatory cytokines such as interleukin (IL)-6, IL-12, tumor necrosis factor (TNF)-α [145], [146]. Recently, it has also been shown that leptin acts as a negative signal for the proliferation of regulatory T cells, while stimulating T helper 1 cells [144], [147]. Thus, leptin may

Clinical applications of leptin

As mentioned earlier, leptin treatment has robust effects in states of leptin deficiency [154] (Fig. 1). Leptin replacement dramatically reduces body weight and fat, and reverses neuroendocrine and metabolic abnormalities in individuals with congenital leptin deficiency [54], [65]. Leptin administration in women with hypothalamic amenorrhea restores normal menstrual cycles, corrects abnormalities in the gonadal, thyroid and adrenal axes, and improves bone mineral density and markers of bone

Concluding remarks

Leptin is an adipocyte-secreted hormone that regulates food intake, energy homeostasis, neuroendocrine function, metabolism, and immune function. Studies have shown that leptin acts mainly on neuronal targets in the brain. Leptin replacement is an effective therapy in severe leptin deficiency, such as congenital leptin deficiency or generalized lipodystrophy. Further studies are needed to better understand the mechanisms underlying leptin resistance in common forms of obesity, and how these

Author contributions

H.K.P and R.S.A co-wrote the review article.

Conflict of interest

There are no potential conflicts of interest relevant to this article.

Acknowledgments

R.S.A is supported by National Institutes of Health grants P01-DK049210 and P30-DK19525.

References (167)

  • I.G. Halatchev et al.

    Peripheral administration of PYY(3–36) produces conditioned taste aversion in mice

    Cell Metab

    (2005)
  • R.L. Batterham et al.

    Critical role for peptide YY in protein-mediated satiation and body-weight regulation

    Cell Metab

    (2006)
  • D. Boey et al.

    PYY transgenic mice are protected against diet-induced and genetic obesity

    Neuropeptides

    (2008)
  • Q. Gao et al.

    Neuronal control of energy homeostasis

    FEBS Lett

    (2008)
  • J.D. Hommel et al.

    Leptin receptor signaling in midbrain dopamine neurons regulates feeding

    Neuron

    (2006)
  • G.M. Leinninger

    Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus

    Physiol Behav

    (2011)
  • C.M. Steppan et al.

    A role for leptin in brain development

    Biochem Biophys Res Commun

    (1999)
  • S.G. Bouret

    Neurodevelopmental actions of leptin

    Brain Res

    (2010)
  • J.L. Chan et al.

    Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa

    Lancet

    (2005)
  • C. Musso et al.

    The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients

    Metabolism

    (2005)
  • G.J. Hausman et al.

    Leptin and reproductive function

    Biochimie

    (2012)
  • C.F. Elias

    Leptin action in pubertal development: recent advances and unanswered questions

    Trends Endocrinol Metab

    (2012)
  • M.A. Sanchez-Garrido et al.

    Metabolic control of puberty: roles of leptin and kisspeptins

    Horm Behav

    (2013)
  • H.R. Kissileff et al.

    Leptin reverses declines in satiation in weight-reduced obese humans

    Am J Clin Nutr

    (2012)
  • Y. Zhang et al.

    Positional cloning of the mouse obese gene and its human homologue

    Nature

    (1994)
  • H.S. Moon et al.

    Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals

    Endocr Rev

    (2013)
  • S. Margetic et al.

    Leptin: a review of its peripheral actions and interactions

    Int J Obes Relat Metab Disord

    (2002)
  • R.V. Considine et al.

    Serum immunoreactive-leptin concentrations in normal-weight and obese humans

    N Engl J Med

    (1996)
  • J.L. Chan et al.

    The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

    J Clin Invest

    (2003)
  • J. Licinio et al.

    Human leptin levels are pulsatile and inversely related to pituitary-adrenal function

    Nat Med

    (1997)
  • M. Rosenbaum et al.

    Clinical review 107: Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin

    J Clin Endocrinol Metab

    (1999)
  • C.T. Montague et al.

    Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution

    Diabetes

    (1997)
  • T. Kelesidis et al.

    Narrative review: the role of leptin in human physiology: emerging clinical applications

    Ann Intern Med

    (2010)
  • C. Bjorbaek et al.

    Expression of leptin receptor isoforms in rat brain microvessels

    Endocrinology

    (1998)
  • D.L. Morris et al.

    Recent advances in understanding leptin signaling and leptin resistance

    Am J Physiol Endocrinol Metab

    (2009)
  • S.H. Bates et al.

    Stat3 signalling is required for leptin regulation of energy balance but not reproduction

    Nature

    (2003)
  • C.S. Mantzoros et al.

    Editorial: leptin as a therapeutic agent—trials and tribulations

    J Clin Endocrinol Metab

    (2000)
  • C.H. Jung et al.

    Molecular mechanisms of central leptin resistance in obesity

    Arch Pharm Res

    (2013)
  • R.S. Ahima et al.

    Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia

    Endocrinology

    (1999)
  • M.A. Cowley et al.

    Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus

    Nature

    (2001)
  • K.W. Kim et al.

    Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus

    Proc Natl Acad Sci U S A

    (2011)
  • G.Y. Liao et al.

    Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin

    Nat Med

    (2012)
  • A.S. Garfield et al.

    Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract

    Endocrinology

    (2012)
  • R.L. Batterham et al.

    Gut hormone PYY(3–36) physiologically inhibits food intake

    Nature

    (2002)
  • T. Riediger

    The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance

    Proc Nutr Soc

    (2012)
  • M. Alvarez Bartolome et al.

    Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty

    Obes Surg

    (2002)
  • Y. Guo et al.

    Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans

    Obesity

    (2006)
  • C.L. Roth et al.

    Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss

    J Clin Endocrinol Metab

    (2005)
  • J.A. Cooper

    Factors affecting circulating levels of peptide YY in humans: a comprehensive review

    Nutr Res Rev

    (2014)
  • W.G. Haynes et al.

    Receptor-mediated regional sympathetic nerve activation by leptin

    J Clin Invest

    (1997)
  • Cited by (464)

    View all citing articles on Scopus
    View full text